BriaCell Therapeutics Corp. Share Price
BCTXBriaCell Therapeutics Corp. Stock Performance
Open $7.80 | Prev. Close $7.02 | Circuit Range N/A |
Day Range $7.01 - $8.02 | Year Range $0.61 - $13.78 | Volume 2,727 |
Average Traded $7.33 |
BriaCell Therapeutics Corp. Share Price Chart
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
BriaCell Therapeutics Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Jan-26 | $7.80 | $7.13 | +0.00% |
06-Jan-26 | $7.80 | $7.13 | -8.06% |
05-Jan-26 | $7.32 | $7.75 | +11.34% |
02-Jan-26 | $7.06 | $6.96 | -2.45% |
31-Dec-25 | $7.59 | $7.14 | -7.15% |
30-Dec-25 | $7.13 | $7.69 | +8.16% |
29-Dec-25 | $7.42 | $7.11 | -12.22% |